Brooklyn ImmunoTherapeutics

-$0.06 (-0.67%) Today
+$0.03 (+0.34%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTX and other ETFs, options, and stocks.

About BTX

Brooklyn ImmunoTherapeutics, Inc. is a clinical stage biopharmaceutical company that develops IRX-2, a novel hd-IL-2 based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells.

CEO
Howard J. Federoff
Employees
22
Headquarters
New York, New York
Founded
—

BTX Key Statistics

Market Cap
494.32M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
482.85K
High Today
$9.09
Low Today
$8.79
Open Price
$8.86
Volume
318.07K
52 Week High
$80.67
52 Week Low
$3.50

BTX Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure